M. H. de Jager

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

P.H. de Jong, Johanna M. W. Hazes, P J Barendregt et al. · Annals of the Rheumatic Diseases · 2012 · 136 citations · Full text

Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)

Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, C. F. Allaart et al. · Annals of the Rheumatic Diseases · 2007 · 66 citations · Full text

Induction of Phase I and II Drug Metabolism in Rat Small Intestine and Colon in Vitro

Esther G. van de Kerkhof, Inge A.M. de Graaf, M. H. de Jager et al. · Drug Metabolism and Disposition · 2007 · 39 citations

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost–utility analysis of the tREACH trial

Pascal H P de Jong, Johanna M. W. Hazes, Leander R. Buisman et al. · Lara D. Veeken · 2016 · 19 citations · Full text

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial

Elise van Mulligen, A. Weel, T. Martijn Kuijper et al. · Annals of the Rheumatic Diseases · 2020 · 19 citations · Full text